人类恶性脑瘤中的长非编码RNA:进展和治疗背后的驱动力
Dakun Pei1, Dandan Zhang1, Yan Guo1
1State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing 400715, China.
International journal of molecular sciences
|January 25, 2025
概括
长非编码RNAs (lncRNAs) 是恶性脑瘤发展的关键调节者. 针对 lncRNA 失调提供了新的治疗策略,以改善癌症治疗结果.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNAs (lncRNAs) 是基因表达的关键调节者.
- lncRNA失调与恶性脑瘤如质母细胞瘤,脑髓母细胞瘤和脑膜瘤的进展有关.
- lncRNA与miRNA,蛋白质和DNA相互作用,影响关键的细胞过程.
研究的目的:
- 审查 lncRNA 失调在恶性脑瘤进展中的作用.
- 突出针对脑癌中 lncRNAs 的治疗潜力.
- 为未来的研究和临床应用提供见解.
主要方法:
- 在恶性脑瘤中对lncRNAs的研究的文献综述.
- 分析lncRNA与其他分子 (miRNA,蛋白质,DNA) 的相互作用.
- 对 lncRNA 参与细胞增殖,迁移和入侵的评估.
主要成果:
- lncRNA失调显著影响恶性脑瘤的进展.
- lncRNAs影响关键的致癌过程,包括细胞增殖,迁移和入侵.
- lncRNAs代表了增强当前癌症治疗的有希望的治疗点.
结论:
- lncRNA失调是恶性脑瘤发展的关键因素.
- 向lncRNAs可能会提高化疗,放射治疗和免疫治疗的疗效.
- 对lncRNA的进一步研究将促进神经瘤学的基础科学和临床实践.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Types of RNA
5.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.6K


